跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Truqap - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Truqap
Approved
STANDARD
Truqap
AstraZeneca AB
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
14885aa429a66b72
Company
AstraZeneca AB
Type
Standard
Approval Details
Approval Id
14885aa429a66b72
Drug Approval Philippines Name
Truqap
Product Name
Truqap
Registration Number
DR-XY49345
Brand Name
Truqap
Generic Name
Capivasertib
Dosage Form
Film-coated tablet
Dosage Strength
160 mg
Manufacturer
AstraZeneca AB
Company Detail Path
/organization/astrazeneca-ab
Issuance Date
28 February 2025
Expiry Date
28 February 2030
Pharmacologic Category
Antineoplastic Agent (Protein Kinase
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
14885aa429a66b72
Type
Standard
Back to Philippines FDA Approvals